Skip to main content
Advanced Science logoLink to Advanced Science
. 2023 Dec 15;11(9):2307078. doi: 10.1002/advs.202307078

Natural Acceptor of Coumarin‐Isomerized Red‐Emissive BioAIEgen for Monitoring Cu2+ Concentration in Live Cells via FLIM

Xu‐Min Cai 1,, Shouji Li 1, Wen‐Jin Wang 2, Yuting Lin 1, Weiren Zhong 1, Yalan Yang 1, Fritz E Kühn 3, Ying Li 4, Zheng Zhao 2,, Ben Zhong Tang 2,
PMCID: PMC10916553  PMID: 38102823

Abstract

Artificial aggregation‐induced emission luminogens (AIEgens) have flourished in bio‐applications with the development of synthetic chemistry, which however are plagued by issues like singularity in structures and non‐renewability. The unique structures and renewability of biomass moieties can compensate for these drawbacks, but their properties are hard to design and regulate due to their confined structures. Therefore, it appears to be a reasonable approach to derive AIEgens from abundant biomass (BioAIEgens), integrating the bilateral advantages of both synthetic and natural AIEgens. In this work, the blue‐violet emissive coumarin with its lactone structure serving as a rare natural acceptor, is utilized to construct donor‐π‐acceptor typed BioAIE isomers incorporating the propeller‐like and electron‐donating triphenylamine (TPA) unit. The results show that Cm‐p‐TPA undergoes charge transfer with its keto form, emitting red light at 600 nm, which can be applied to monitor Cu2+ concentration during mitophagy using fluorescence lifetime imaging microscopy because of the excellent biocompatibility, photostability, and specific recognition to Cu2+. This work not only demonstrates the feasibility of utilizing positional isomerization to modulate excited‐state evolutions and resultant optical properties, but also provides evidence for the rationality of constructing biologically‐active BioAIEgens via a biomass‐derivatization concept.

Keywords: BioAIEgen, copper sensor, coumarin, FLIM, red emission


This work not only demonstrates the feasibility of utilizing positional isomerization to modulate excited‐state evolutions and produce a red‐emissive BioAIEgen to be applied to monitor the Cu2+ concentration in live cells using FLIM, but also provides evidence for the rationality of constructing biologically‐active BioAIEgens via a biomass‐derivatization concept.

graphic file with name ADVS-11-2307078-g003.jpg

1. Introduction

Currently, petrochemical‐based aggregation‐induced emission (AIE) materials with outstanding optical properties are widely applied in phototherapy, as bio‐sensors, in anti‐counterfeiting, and several other fields.[ 1 ] However, these synthetic AIE materials are mostly derived from molecular scaffolds such as tetraphenylethylene (TPE) and triphenylamine (TPA), which have limitations with respect to accessible structures and are non‐renewable. This may hamper the further development of novel AIE materials. AIE materials derived from biomass or possessing natural skeletons (BioAIEgens)[ 2 ] in contrast can compensate for these limitations, due to their unique natural structures, their renewability, and their inherent biocompatibility.[ 3 ] In recent years, more and more natural products, such as quercetin,[ 4 ] kaempferol,[ 5 ] berberine,[ 6 ] tanshinone,[ 7 ] and coumarin,[ 8 ] have been found to exhibit AIE properties, showing great potential in bioimaging and therapeutics. However, most of the purely natural BioAIEgens are difficult to extract and confined to fixed structures, making it difficult to optimize their luminescence properties. Therefore, the utilization of proper and abundant biomass moieties as starting materials for tunable, multifunctional, and renewable BioAIEgens with novel structures through chemical modification is of great interest (Figure 1 ).[ 2 , 9 ]

Figure 1.

Figure 1

The comprehensive advantages of BioAIEgens derived from biomass.

AIEgens with long‐wavelength emission are commonly used in the fields of bioimaging and therapeutics due to their advantages such as deep tissue penetration, low photo‐damage, and low scattering effects.[ 10 ] BioAIEgens always show good bio‐compatibility, making them excellent candidates for vivo‐applications. However, as far as we know, only Tang's group reported a purely natural case of tanshinone‐based BioAIEgen with red emission for photodynamic therapy.[ 7 ] Therefore, more red‐emissive BioAIEgens via molecular design strategies for bio‐applications based on biomass resources would be highly desirable.

It is well known that long‐wavelength emission can be achieved by constructing a donor‐π‐acceptor (D‐π‐A) structure to induce a charge transfer (CT) effect.[ 11 ] Coumarin is a common natural product with an unsatisfying blue‐violet emission[ 2c ] that cannot be utilized for practical applications. Nevertheless, its lactone structure can be regarded as a rare natural acceptor[ 12 ] for constructing D‐π‐A typed red‐emissive BioAIEgens. Besides, the subtle differences in structural isomers may result in the distinction of CT properties. For instance, Wang et al. have studied the effect of structural isomerization on the resultant near‐infrared properties, and found that the para‐substituted isomer possesses stronger D–A interaction and red‐shifted emission.[ 13 ] In addition, the influence of ortho, meta, and para positions on the intramolecular CT effect of phenothiazine‐fused benzothiazoles has been investigated, discovering that the para‐substituted isomer exhibits stronger intramolecular CT characteristics due to a smaller torsion angle and enhanced conjugation.[ 14 ] Therefore, we assumed it is possible to achieve red‐emissive coumarin‐based BioAlEgens as specific metal sensors with chelating salicylaldehyde Schiff base structures via the introduction of TPA at variable positions of the π bridge with tunable CT properties (Scheme 1a).

Scheme 1.

Scheme 1

a) Molecular design of coumarin‐derived BioAIEgens. CT@enol, and CT@keto represent for CT in the enol and keto forms, respectively. b) Diagram of monitoring the concentration variation of Cu2+ during mitophagy via FLIM based on Cm‐p‐TPA in cells. FLIM is especially adapted to the turn‐off sensors compared to turn‐on ones.

Copper is an essential trace element in biological systems and plays specific biological roles in organisms.[ 15 ] The imbalance of copper inside cells can disrupt cellular functions, hence the copper content is strictly regulated. Previous studies have shown that copper ions play a significant role in mitochondrial biosynthesis and the respiratory chain.[ 16 ] Mitophagy is an intercellular self‐renewal process that selectively eliminates redundant or damaged mitochondria, which indeed can lead to changes in copper ion concentration and potentially affect the entire copper ion transfer network. However, to the best of our knowledge, there have been no reports on the changes of copper ion concentration during mitophagy. Traditional intensity‐based probes are limited by their concentration‐dependent characteristics and the extent of dye uptaken by cells. Especially with respect to turn‐off sensors, they can neither be applied in intensity‐based probing methods nor provide direct visual observation. In contrast, the fluorescence lifetime imaging microscopy (FLIM) method has attracted widespread attention because of its high‐resolution and sensitivity to the cellular microenvironment, independent of the concentration of the dye. However, the reported Cu+ sensor is completely synthetic and not economically applicable.[ 17 ] Thus, by using the red‐emissive and biocompatible BioAIEgen as a specific copper sensor, in conjunction with the FLIM method, it should be possible to detect and visualize the variation of copper during mitophagy and disclose the role of copper in the cellular mitophagy (Scheme 1b).

In this work, the coumarin‐based position‐isomerized BioAIEgens (Cm‐o‐TPA and Cm‐p‐TPA) were successfully obtained through introducing a propeller‐shaped and electron‐donating TPA group on the ortho‐ and para‐position of the coumarin structure. The results demonstrate that the coumarin structure can indeed work as a natural acceptor to construct D‐π‐A molecules and that the positional isomerism shows a significant influence on the CT effect. The ortho‐substituted Cm‐o‐TPA exhibits CT in the enol state, while the para‐substituted Cm‐p‐TPA exhibits CT in the keto state, with the latter resulting in red emission. Furthermore, based on the biocompatibility, red emission, and specific recognition toward Cu2+ of Cm‐p‐TPA, the FLIM method can be successfully employed to monitor the concentration changes of Cu2+ during mitophagy, indicating a continuous increase in Cu2+ concentration during mitophagy.

2. Results and Discussion

2.1. Synthesis and Characterization

As shown in Schemes S1 and S2 (Supporting Information), Cm‐CHO was reacted with TPA‐o‐NH2 , TPA‐p‐NH2 , Ph‐NH2 , Ph‐o‐NH2 , and Ph‐p‐NH2 through a simple Schiff base reaction to obtain the target molecules Cm‐o‐TPA and Cm‐p‐TPA, as well as the control molecules Cm‐Ph, Cm‐o‐Ph, and Cm‐p‐Ph. All compounds were characterized using 1H NMR, 13C NMR, and HRMS (Figures S1–S16, Supporting Information).

2.2. ESIPT‐CT‐AIE Properties of Cm‐o‐TPA and Cm‐p‐TPA

The photophysical properties of Cm‐o‐TPA and Cm‐p‐TPA in their molecular state have been explored at first. In Figure 2a, Cm‐p‐TPA exhibits an additional absorption peak at 380 nm compared to Cm‐o‐TPA, possibly attributable to the CT absorption peak.[ 18 ] In the photoluminescence (PL) spectra, the two emission peaks at 397 and 554 nm for Cm‐o‐TPA can be assigned to the enol and keto peaks, respectively, typically accompanied with the excited‐state intramolecular proton transfer (ESIPT) process.[ 19 ] Cm‐p‐TPA only exhibits a single keto peak,[ 20 ] indicating that Cm‐p‐TPA is more favorable for ESIPT. It is assumed that the para‐substituted Cm‐p‐TPA with less steric hindrance is more inclined to experience ESIPT and CT processes at the molecular level. As shown in Table S1 (Supporting Information), the quantum yields (QYs) of Cm‐o‐TPA and Cm‐p‐TPA in tetrahydrofuran (THF)/H2O mixtures with different water fractions (f w) = 0% are 3.10% and 5.72%, respectively, which are of no big difference. However, when visually inspecting the fluorescence pictures, Cm‐o‐TPA shows weaker emission than Cm‐p‐TPA. That might because Cm‐o‐TPA exhibits both enol and keto emissions, with the enol emission falling in the UV‐violet region not sensitive to the naked eye. Cm‐p‐TPA exhibits a sole keto emission in the visible region, hence exhibiting stronger emission to the naked eye. Next, the photophysical properties of two isomers in their aggregated states have been further investigated. As shown in Figure 2b, it can be clearly observed that the fluorescence intensity of both isomers in THF/H2O mixtures exhibits a trend of decreasing and then increasing with increased f w, indicating their CT and AIE characteristics.[ 21 ] Cm‐p‐TPA exhibits a more pronounced redshift in its aggregated state, which may be attributed to the different CT evolution processes. To further verify this, the corresponding PL test was carried out (Figure 2c,d). With the increase of f w, the intensities of the enol peaks of both isomers exhibit an initial enhancement followed by a decrease, while the keto peaks show the opposite trend (Figure S17, Supporting Information). This is consistent with the fluorescence phenomenon, indicating that aggregation at high f w (Figure S18, Supporting Information) facilitates the ESIPT process and promotes the formation of keto structures, leading to the ESIPT‐induced AIE performance.[ 9 , 20 ] The concentration effect further confirms their AIE properties (Figure S19, Supporting Information). Interestingly, the enol peaks of Cm‐o‐TPA exhibit a more pronounced wavelength shift with increased f w compared to the keto peaks, while the opposite way is observed for Cm‐p‐TPA. This indicates that the positional isomerism may have a significant impact on the excited‐state CT process. Through a solvent effect test (Figure 2e; Figure S20, Supporting Information), it is found that with changes in polarity, the emission wavelength of the enol peaks of Cm‐o‐TPA differ by 22 nm, while those of the keto peaks of Cm‐p‐TPA show a significant shift of 17 nm. Therefore, Cm‐o‐TPA indeed exhibits CT in the enol form, while Cm‐p‐TPA shows CT in the keto form. The above‐described results suggest that a para‐substitution is more inclined to experience ESIPT to result in the keto structure, subsequently followed by the CT process. The synergistic excited‐state evolutions of ESIPT and CT can result in the red emission of Cm‐p‐TPA. This conclusion is further supported by a study of control molecules. Cm‐Ph without donor moiety only exhibits ESIPT‐AIE performance (Figure S21, Supporting Information), while the donor incorporation of a benzene ring in both Cm‐o‐Ph and Cm‐p‐Ph results in similar spectroscopic properties to those of Cm‐o‐TPA and Cm‐p‐TPA (Figures S22 and S23, Supporting Information), further confirming that the para‐substitution strategy on the D‐π‐A scaffold is more conducive to initiate CT process after ESIPT, hence leading to the red emission.

Figure 2.

Figure 2

a) Normalized absorption and PL spectra of Cm‐o‐TPA and Cm‐p‐TPA in pure THF solution. Concentration: 10 µm. Cm‐o‐TPA (λ ex: 309 nm) and Cm‐p‐TPA (λ ex: 380 nm). b) Fluorescence photographs of Cm‐o‐TPA and Cm‐p‐TPA in tetrahydrofuran (THF)/H2O mixtures with different water fractions (f w) taken under 365 nm UV irradiation. Concentration: 10 µm. c,d) PL spectra of Cm‐o‐TPA c) (λ ex: 309 nm) and Cm‐p‐TPA d) (λ ex: 380 nm) in THF/H2O mixtures with different f w. Concentration: 10 µm. e) PL spectra of Cm‐o‐TPA and Cm‐p‐TPA in solvents with different polarities. Concentration: 10 µm. The absorption maximum of each solution was chosen as its excitation wavelength.

2.3. Photophysical Properties in the Aggregate States

Based on the variable CT processes revealed in the molecular state, the photophysical properties in the aggregate states have been further studied. In the water rich fraction (f w = 90%), Cm‐p‐TPA exhibits an emission peak at ≈600 nm, exhibiting redder emission compared to Cm‐o‐TPA (wavelength: 550 nm) (Figure 3a). Interestingly, both Cm‐o‐TPA (wavelength: 570 nm) and Cm‐p‐TPA (wavelength: 600 nm) exhibit similar fluorescence properties (Figure 3b) in the crystalline states verified by the strong and sharp diffraction peaks found in the powder X‐ray (PXRD) diffraction measurement (Figure S24, Supporting Information). When comparing their emission intensity at both molecular and aggregate states (Table S1, Supporting Information), Cm‐o‐TPA shows stronger emission in the aggregate states (QY = 3.10%, 9.52%, and 12.70% at fw  = 0%, 90%, and solid state, respectively), most probably due to the restriction of molecular motion. Interestingly, Cm‐p‐TPA exhibits the opposite way, with the QY value larger at molecular level (5.72%) than that in the aggregate states (1.09% and 0.60% at fw  = 90% and solid state, respectively). This might be attributed from its planar conformation at aggregate state that can contribute to the charge transfer in the keto emission, hence causing a redshift and more energy dissipation through non‐radiative channels, resulting in a decreased QY. A single crystal of Cm‐p‐TPA was used for further clarification (Figure 3c; Table S2, Supporting Information). According to the conformation of Cm‐p‐TPA, the intramolecular hydrogen bond length in the crystal structure is 1.85(1) Å, favoring the occurrence of an ESIPT process.[ 20 ] The torsion angles (−160(1)° and 178(1)°) indicate planar conformation, which facilitates the CT process to cause red emission. Moreover, different views of molecular packing reveal a staggered arrangement and larger intermolecular distances (5.550(1), 4.120(1), and 4.1676(9) Å), suggesting weak intermolecular interactions that account for the weak fluorescence. Nevertheless, the crystallographic results reaffirm that the red emission of Cm‐p‐TPA is caused by the CT process after ESIPT via a positional substitution strategy.

Figure 3.

Figure 3

a,b) Normalized PL spectra of Cm‐o‐TPA (λ ex: 360 nm) and Cm‐p‐TPA (λ ex: 380 nm) in THF/H2O mixtures with f w = 90% a) and as solid b). Inset: fluorescence photographs of Cm‐o‐TPA and Cm‐p‐TPA at respective states, taken under 365 nm UV irradiation. c) Molecular conformation (top) and packing (bottom) of Cm‐p‐TPA. Inset: a red single crystal of Cm‐p‐TPA.

2.4. Spectroscopic and Lifetime Studies of Cm‐p‐TPA to Cu2+ In Vitro

The above‐described BioAIEgens featuring ─OH and ─C═N─ groups can coordinate with metal ions to form stable hexacoordinated chelates, resulting in a potential metal ion sensor.[ 22 ] Due to the smaller steric hindrance of Cm‐p‐TPA compared to Cm‐o‐TPA, it may exhibit stronger coordinating ability with metal ions. Hence, Cm‐p‐TPA has been selected as a sensor for the in vitro studies. According to the results shown in Figure 4a and Figure S25 (Supporting Information), it can be observed that both the absorption and PL spectra of Cm‐p‐TPA have been affected by Cu2+ when ten different metal ions (Ag+, Ni+, Pb2+, Cd2+, Cu2+, Mg2+, Zn2+, Al3+, Ce2+, and Fe3+) are added to the THF/PBS (f w = 80%) mixture, suggesting the specific recognition of Cu2+ with Cm‐p‐TPA. The fluorescence quenching of Cm‐p‐TPA upon complexation with Cu2+ may be attributed to ligand‐metal charge transfer.[ 23 ] Comparative experiments further confirm that the para‐position exhibits stronger selectivity toward Cu2+ (vide supra). As shown in the fluorescence images (Figure S26c,d, Supporting Information), it is evident that the fluorescence of Cm‐p‐TPA is quenched after adding Cu2+, while Cm‐o‐TPA doesn't show such behavior, indicating the stronger coordination ability of Cm‐p‐TPA. In addition, both the absorption and PL spectra of Cm‐o‐TPA (Figure S26a,c, Supporting Information) remain almost unchanged after adding Cu2+, whereas those of Cm‐p‐TPA (Figure S26b,d, Supporting Information) undergo noticeable changes, further indicating the stronger coordination of Cm‐p‐TPA with Cu2+. Additionally, Figure 4b demonstrates that even in the presence of other metal ions, the addition of Cu2+ significantly reduces the fluorescence intensity of Cm‐p‐TPA, suggesting that the recognition of Cu2+ by Cm‐p‐TPA is not influenced by other metal ions. Furthermore, it can be observed that the PL intensity of Cm‐p‐TPA gradually decreases as the concentration of Cu2+ increases from 0 to 10 µm (Figure 4c). The calculated lower limit of detection of Cm‐p‐TPA is 0.205 × 10−6 m (S/N = 3) (Figure S27, Supporting Information), suitable as Cu2+ sensor in biological systems.[ 24 ] Since Cm‐p‐TPA demonstrates fluorescence quenching upon complexation with Cu2+, it is more adaptable to monitor the changes of Cu2+ concentration using the FLIM method. The lifetime changes of Cm‐p‐TPA upon binding with Cu2+ in vitro have been first tested (Figure 4d; Figure S28, Supporting Information). As shown in Figure 4d, when 0 to 500 µm Cu2+ was added to Cm‐p‐TPA, the fluorescence lifetime of Cm‐p‐TPA significantly increased after binding with Cu2+. Two lifetime components (τ 1 and τ 2) were extracted from the decay fitting values. The short lifetime τ 1 can be assigned to Cm‐p‐TPA, while the long lifetime τ 2 is assigned to the complex formed by Cm‐p‐TPA and Cu2+. The decrease in τ 1 indicates gradual coordination between Cm‐p‐TPA and Cu2+, resulting in fluorescence quenching and a shorter lifetime. The increase in τ 2 indicates the increasing amount of the complex formed by Cm‐p‐TPA and Cu2+, leading to fluorescence quenching and a longer lifetime. This indicates that the FLIM method can be applied to monitor changes of Cu2+ concentration in vitro.

Figure 4.

Figure 4

a) The PL spectra of Cm‐p‐TPA (10 µm) in the presence of different metal ions (100 µm) including Cu2+ in THF/PBS (v/v = 20/80, pH 7.4). Inset: the photography of the corresponding metal ion mixture solutions under a 365 nm UV lamp. b) PL intensities of Cm‐p‐TPA (10 µm) alone (blank), blank + various metal ions (100 µm), and blank + metal ions + Cu2+ (100 µm) in THF/PBS (v/v = 20/80, pH 7.4) solution, λ ex = 380 nm. c) Fluorescence titration spectra of Cm‐p‐TPA (10 µm) upon addition of a Cu2+ (0–10 µm) in THF/PBS (v/v = 20/80, pH 7.4) solution. d) The fluorescence lifetime decay curves of Cm‐p‐TPA (10 µm) with increasing amounts of Cu2+ in PBS buffer (pH 7.4). Inset: fitting parameters.

2.5. Targeted Imaging of Lysosomes by Cm‐p‐TPA Nanoparticles

Considering Cm‐p‐TPA has potential in Cu2+ sensing in vitro, it is a good choice to utilize this natural scaffold‐derived BioAIEgen for monitoring in biological systems. To clarify the utilization form of Cm‐p‐TPA, the long‐term chemical and optical stability of Cm‐p‐TPA (with/without Pluronic F127 encapsulation) in Dulbecco's Modified Eagle Medium (DMEM) with 10% fetal bovine serum (FBS) as a supplement have been examined. As shown in Figure S29 (Supporting Information), we first examined the chemical stability of Cm‐p‐TPA within 48 h and observed a gradual decrease in absorption intensity over time, suggesting that its chemical stability was suboptimal. However, upon encapsulating it with F127, the chemical stability was significantly improved within these 48 h. Then we evaluated the photostability and observed a decreasing trend in both the absorption and fluorescence intensities of Cm‐p‐TPA with increasing light exposure time (Figure S30a,c,d,f, Supporting Information). Nevertheless, when combined with F127, the absorption intensity remained almost unchanged, and the fluorescence intensity only showed a slight decrease (Figure S30b,c,e,f, Supporting Information). These findings highlight the advantages of incorporating F127 to enhance the chemical and photostability of Cm‐p‐TPA, thus the Pluronic F127 encapsulated Cm‐p‐TPA nanoparticles (NPs) verified by dynamic light scattering (DLS) and transmission electron microscope (TEM) results (Figure S31, Supporting Information) have been applied for all intracellular experiments since either Cm‐p‐TPA itself or Cm‐p‐TPA NPs exhibits a response to Cu2+ in a fluorescence quenching effect (Figure S32, Supporting Information). First, both the cytotoxicity and photocytotoxicity of Cm‐p‐TPA NPs have been investigated by MTT assays (Figures S33 and S34, Supporting Information). The results confirm that the IC50 values for non‐light and light treatment groups are found to be above 200 and 180 µm, respectively, demonstrating their superior biocompatibility to be suitably applied in cell imaging. In addition, its photostability in HeLa cells is tested (Figure S35, Supporting Information). With increasing irradiation time from 0 to 1200 s, the fluorescence intensity keeps nearly invariable, suggesting that Cm‐p‐TPA NPs exhibit good photostability. Furthermore, we have evaluated the targeting ability of Cm‐p‐TPA NPs to cellular organelles in HeLa cells (Figure S36, Supporting Information). Through the co‐localization experiments of Cm‐p‐TPA NPs with LysoTracker Deep Red FM (LTDR) and MitoTracker Green FM (MTG), it is found that Cm‐p‐TPA NPs could target lysosomes with a good Pearson correlation coefficient (PCC: 0.84). The above described cell experimental results indicate that Cm‐p‐TPA NPs have low cytotoxicity, photocytotoxicity, and good photostability in HeLa cells, and they can image lysosomes their in.

2.6. FLIM Imaging of Cu2+ Changes During Mitophagy Using Cm‐p‐TPA Nanoparticles

Currently, copper ions play an important role in mitochondrial biosynthesis and respiratory chain function. Mitophagy may lead to changes in copper ion concentration and may affect the entire copper ion transfer network. Since Cm‐p‐TPA containing natural coumarin structure, red emission, and recognition of Cu2+ can image lysosome specifically, it has the potential to monitor copper ion changes during mitophagy. To ensure that mitochondrial autophagy is successfully initiated, the expression level of key signaling proteins for mitophagy was determined by western blot assays (Figure S37a, Supporting Information) and the morphological changes of mitochondria for mitophagy was monitored by TEM (Figure S37b, Supporting Information). The results of western blot indicate that nutritional deprivation for 2 h could induce significant up‐regulation of mitophagy associated Parkin and PINK1. Furthermore, up‐regulation of LC3‐II indicates the formation of autophagosome, which also could be verified by the autophagic structure in the TEM images. Considering the co‐existence of Cu+ in biological systems, we have conducted a control experiment (Figure S38, Supporting Information) to investigate whether Cm‐p‐TPA is also affected by Cu+. The results show that the fluorescence of Cm‐p‐TPA aggregates is not quenched when Cu+ is added, indicating that it is not affected by Cu+. Next, Cm‐p‐TPA NPs have been applied to the actual mitophagy process in HeLa cells. Cm‐p‐TPA NPs were co‐incubated with HeLa cells for 12 h. Then, the HeLa cells were starved in a D‐Hanks buffer for 2 h to induce apoptosis and trigger mitophagy. The cells were labeled with LTDR, and MTG 15 min before imaging by confocal microscopy. In Figure 5 , the Overlay and PCC columns of LTDR and MTG demonstrate that at 0 min, the PCC between mitochondria and lysosomes in HeLa cells is low (0.32), indicating that the mitophagy process has just started. After 20 min, the PCC between mitochondria and lysosomes increases to 0.63, indicating that the mitophagy process is more than halfway complete. Within the 0 to 20 min timeframe, it is observed that the fluorescence intensity locating in the lysosomes gradually decreases. These results suggest the release of Cu2+ during the mitophagy process since both the chemical‐ and photo‐bleaching effects are out of consideration due to pronounced chemical‐ and photo‐stability (vide supra). It is inferred that Cu2+ coordinates with Cm‐p‐TPA, and the concentration of Cu2+ gradually increases during mitophagy.

Figure 5.

Figure 5

Monitoring the mitophagy process using Cm‐p‐TPA NPs (10 µm). The HeLa cells were incubated with Cm‐p‐TPA NPs (10 µm) for 12 h before starved in D‐Hanks for 2 h. Then, the cells were incubated with LTDR (200 nm) and MTG (200 nm) for 15 min before imaging using confocal microscopy. Cm‐p‐TPA NPs: λ ex = 405 nm; λ em = 590 ± 20 nm. MTG: λ ex = 490 nm; λ em = 516 ± 20 nm. LTDR: λ ex = 633 nm; and λ em = 670 ± 20 nm. Scale bars: 10 µm.

To shed more light, FLIM has been used to monitor the changes in Cu2+ concentration during mitophagy in HeLa cells. Changes in the fluorescence lifetime of Cm‐p‐TPA NPs within the lysosomes (Figure 6 ) also exhibits similar results to the in vitro experiments. Within 0 to 20 min, the lysosomes stained with Cm‐p‐TPA NPs show a gradual decrease in the short lifetime τ 1, resulting in a color change from yellow‐green to green in the imaging. On the other hand, the long lifetime τ 2 gradually increases, resulting in a color change from light orange to dark orange in the imaging. As a result, it is clear that the concentration of Cu2+ increases gradually during the mitophagy process in HeLa cells, in addition to the fluorescence quenching in lysosome imaging (vide supra).

Figure 6.

Figure 6

The lifetime changes of Cm‐p‐TPA NPs (10 µm) during the starvation‐inducing mitophagy process of HeLa cells. Scale bar: 10 µm.

3. Conclusion

In summary, we successfully transformed the natural acceptor of blue‐violet emissive coumarin into its derived BioAIEgens (Cm‐o‐TPA and Cm‐p‐TPA) with distinct ESIPT‐CT‐AIE properties by introducing TPA through positional isomerization. Specifically, Cm‐o‐TPA exhibits CT in its enol form, while Cm‐p‐TPA exhibits CT in the keto form, leading to red emission. Additionally, single‐crystal analysis shows that the introduction of para‐substituted TPA results in a planar conformation for stronger CT, leading to a redshift. Furthermore, based on the good biocompatibility, red emission, and specific recognition of Cu2+ by Cm‐p‐TPA NPs, it has been successfully applied to monitor the changes in Cu2+ concentration during the mitophagy process in HeLa cells using the FLIM method.

Conflict of Interest

The authors declare no conflict of interest.

Supporting information

Supporting Information

Acknowledgements

X.‐M.C., S.L., and W.‐J.W. contributed equally to this work. The authors are grateful for the support from the National Natural Science Foundation of China (21601087 and 22307108), the Natural Science Foundation of Jiangsu Province (BK20231296), the Shenzhen Key Laboratory of Functional Aggregate Materials (ZDSYS20211021111400001), the Science Technology Innovation Commission of Shenzhen Municipality (KQTD20210811090142053), and the Key Research and Development Project of Yunnan Province (202303AC100010). The authors also thank the AIE Institute (www.aietech.org.cn) for providing some AIE materials and technical assistance as well as Professor Zhipeng Liu for valuable discussions.

Cai X.‐M., Li S., Wang W.‐J., Lin Y., Zhong W., Yang Y., Kühn F. E., Li Y., Zhao Z., Tang B. Z., Natural Acceptor of Coumarin‐Isomerized Red‐Emissive BioAIEgen for Monitoring Cu2+ Concentration in Live Cells via FLIM. Adv. Sci. 2024, 11, 2307078. 10.1002/advs.202307078

Contributor Information

Xu‐Min Cai, Email: xumin.cai@njfu.edu.cn.

Zheng Zhao, Email: zhaozheng@cuhk.edu.cn.

Ben Zhong Tang, Email: tangbenz@cuhk.edu.cn.

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.

References

  • 1.a) Cai X., Liu B., Angew. Chem. Int. Ed. 2020, 59, 9868; [DOI] [PubMed] [Google Scholar]; b) Cen P., Huang J., Jin C., Wang J., Wei Y., Zhang H., Tian M., Aggregate 2023, 4, e352; [Google Scholar]; c) Huang G., Xia Q., Huang W., Tian J., He Z., Li B. S., Tang B. Z., Angew. Chem. Int. Ed. 2019, 58, 17814; [DOI] [PubMed] [Google Scholar]; d) Kwok R. T. K., Leung C. W. T., Lam J. W. Y., Tang B. Z., Chem. Soc. Rev. 2015, 44, 4228; [DOI] [PubMed] [Google Scholar]; e) Li H., Kim H., Han J., Nguyen V.‐N., Peng X., Yoon J., Aggregate 2021, 2, e51; [Google Scholar]; f) Mei J., Leung N. L. C., Kwok R. T. K., Lam J. W. Y., Tang B. Z., Chem. Rev. 2015, 115, 11718; [DOI] [PubMed] [Google Scholar]; g) Li Y., Liu F., Zhang J., Liu X., Xiao P., Bai H., Chen S., Wang D., Sung S. H. P., Kwok R. T. K., Shen J., Zhu K., Tang B. Z., Adv. Sci. 2021, 8, 2001750. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.a) Guo T., Lin Y., Pan D., Zhang X., Zhu W., Cai X.‐M., Huang G., Wang H., Xu D., Kühn F. E., Zhang B., Zhang T., Nat. Commun. 2023, 14, 6076; [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Cai X.‐M., Lin Y., Li Y., Chen X., Wang Z., Zhao X., Huang S., Zhao Z., Tang B. Z., Nat. Commun. 2021, 12, 1773; [DOI] [PMC free article] [PubMed] [Google Scholar]; c) Cai X.‐M., Lin Y., Zhang J., Li Y., Tang Z., Zhang X., Jia Y., Wang W., Huang S., Alam P., Zhao Z., Tang B. Z., Natl. Sci. Rev. 2023, 10, nwad233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.a) Huang S., Zhong W., Zhang X., Li S., Cai X.‐M., J. For. Eng. 2022, 7, 34; [Google Scholar]; b) Lee M. M. S., Yu E. Y., Chau J. H. C., Lam J. W. Y., Kwok R. T. K., Wang D., Tang B. Z., Biomaterials 2022, 288, 121712; [DOI] [PubMed] [Google Scholar]; c) Liu D., Zhao Z., Tang B. Z., Sci. Sin. Chim. 2022, 52, 1524. [Google Scholar]
  • 4. He T., Niu N., Chen Z., Li S., Liu S., Li J., Adv. Funct. Mater. 2018, 28, 1706196. [Google Scholar]
  • 5. Sun L., Wang X., Shi J., Yang S., Xu L., Spectrochim. Acta A Mol. Biomol. Spectrosc. 2021, 249, 119303. [DOI] [PubMed] [Google Scholar]
  • 6. Gu Y., Zhao Z., Su H., Zhang P., Liu J., Niu G., Li S., Wang Z., Kwok R. T. K., Ni X.‐L., Sun J., Qin A., Lam J. W. Y., Tang B. Z., Chem. Sci. 2018, 9, 6497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Lee M. M. S., Wu Q., Chau J. H. C., Xu W., Yu E. Y., Kwok R. T. K., Lam J. W. Y., Wang D., Tang B. Z., Cell Rep. Phys. Sci. 2022, 3, 100803. [Google Scholar]
  • 8. Chen S.‐S., Wang H., Wu B., Li Q., Gong J., Zhao Y.‐L., Zhao Y., Xiao X., Lam J. W. Y., Zhao Z., Luo X.‐D., Tang B. Z., ACS Cent. Sci. 2023, 9, 883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.a) Cai X.‐M., Lin Y., Tang Z., Zhang X., Mu T., Huang S., Zhao Z., Tang B. Z., Chem. Eng. J. 2023, 451, 138627; [Google Scholar]; b) Cai X.‐M., Tang Z., Chen X., Lin Y., Zhang X., Huang S., Dyes Pigm. 2022, 204, 110454; [Google Scholar]; c) Liu Q.‐S., Yang Z.‐H., Wang Z.‐L., Sun Y., Chen L.‐L., Sun L., Sun X.‐B., Gu W., J. Photochem. Photobiol. A 2022, 423, 113597; [Google Scholar]; d) Xiong Y., Zhong W., Zhang X., Lin Y., Tang Z., Li S., Cai X.‐M., Dyes Pigm. 2023, 218, 111475; [Google Scholar]; e) Gong S., Qin A., Zhang Y., Tian J., Li M., Liang Y., Xu X., Wang Z., Wang S., ACS Sustainable Chem. Eng. 2023, 11, 15114; [Google Scholar]; f) Gu Z., Lu W., Xue H., Zhang J., Yang S., Xu L., Fitoterapia 2022, 161, 105232. [DOI] [PubMed] [Google Scholar]
  • 10. Guo Z., Yan C., Zhu W.‐H., Angew. Chem. Int. Ed. 2020, 59, 9812. [DOI] [PubMed] [Google Scholar]
  • 11.a) Hu L., Pan J., Zhang C., Yu K., Shen S., Wang Y., Shen X., Gu X., Han J., Wang H., Biosens. Bioelectron. 2022, 216, 114618; [DOI] [PubMed] [Google Scholar]; b) Rémond M., Hwang J., Kim J., Kim S., Kim D., Bucher C., Bretonnière Y., Andraud C., Kim E., Adv. Funct. Mater. 2020, 30, 2004831; [Google Scholar]; c) Wang T., Jiang Z., Liu Z., Org. Lett. 2023, 25, 1638; [DOI] [PubMed] [Google Scholar]; d) Chen L., Lv B., Wang Z., Sun L., Sun X., Li J., Gu W., Dyes Pigm. 2023, 220, 111680. [Google Scholar]
  • 12.a) Jana K., Sarkar D., Jaiswal P., Moorthy J. N., J. Org. Chem. 2023, 88, 6611; [DOI] [PubMed] [Google Scholar]; b) Qian R., Tong H., Huang C., Li J., Tang Y., Wang R., Lou K., Wang W., Org. Biomol. Chem. 2016, 14, 5007; [DOI] [PubMed] [Google Scholar]; c) Shreykar M. R., Sekar N., Dyes Pigm. 2017, 142, 121; [Google Scholar]; d) Huang Z., Ding A., Yang J., Wang C., Tang F., Chem.Eur. J. 2023, 29, e202203628; [DOI] [PubMed] [Google Scholar]; e) Yan H., Meng X., Li B., Ge S., Lu Y., Dyes Pigm. 2017, 146, 479. [Google Scholar]
  • 13. Feng L., Li C., Liu L., Chen X., Jiang G., Wang J., Tang B. Z., Angew. Chem. Int. Ed. 2022, 61, e2022126. [DOI] [PubMed] [Google Scholar]
  • 14. Ekbote A., Mobin S. M., Misra R., J. Mater. Chem. C 2020, 8, 3589. [Google Scholar]
  • 15.a) Chen L., Min J., Wang F., Signal Transduct. Target. Ther. 2022, 7, 378; [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Chen X., Cai Q., Liang R., Zhang D., Liu X., Zhang M., Xiong Y., Xu M., Liu Q., Li P., Yu P., Shi A., Cell Death Dis. 2023, 14, 105; [DOI] [PMC free article] [PubMed] [Google Scholar]; c) Kepp K. P., Squitti R., Coord. Chem. Rev. 2019, 397, 168. [Google Scholar]
  • 16.a) Garza N. M., Swaminathan A. B., Maremanda K. P., Zulkifli M., Gohil V. M., Trends Endocrinol. Metal. 2023, 34, 21; [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Ramchandani D., Berisa M., Tavarez D. A., Li Z., Miele M., Bai Y., Lee S. B., Ban Y., Dephoure N., Hendrickson R. C., Cloonan S. M., Gao D., Cross J. R., Vahdat L. T., Mittal V., Nat. Commun. 2021, 12, 7311; [DOI] [PMC free article] [PubMed] [Google Scholar]; c) Xue Q., Kang R., Klionsky D. J., Tang D., Liu J., Chen X., Autophagy 2023, 19, 2175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.a) Doll F., Buntz A., Späte A.‐K., Schart V. F., Timper A., Schrimpf W., Hauck C. R., Zumbusch A., Wittmann V., Angew. Chem. Int. Ed. 2016, 55, 2262; [DOI] [PubMed] [Google Scholar]; b) Ouyang Y., Liu Y., Wang Z. M., Liu Z., Wu M., Nanomicro Lett. 2021, 13, 133; [DOI] [PMC free article] [PubMed] [Google Scholar]; c) Priessner M., Summers P. A., Lewis B. W., Sastre M., Ying L., Kuimova M. K., Vilar R., Angew. Chem. Int. Ed. 2021, 60, 23148; [DOI] [PMC free article] [PubMed] [Google Scholar]; d) Summers P. A., Lewis B. W., Gonzalez‐Garcia J., Porreca R. M., Lim A. H. M., Cadinu P., Martin‐Pintado N., Mann D. J., Edel J. B., Vannier J. B., Kuimova M. K., Vilar R., Nat. Commun. 2021, 12, 162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Pinjari D., Alsaleh A. Z., Patil Y., Misra R., D'souza F., Angew. Chem. Int. Ed. 2020, 59, 23697. [DOI] [PubMed] [Google Scholar]
  • 19. Zhou P., Han K., Aggregate 2022, 3, e160. [Google Scholar]
  • 20. Cai X.‐M., Zhong W., Deng Z., Lin Y., Tang Z., Zhang X., Zhang J., Wang W., Huang S., Zhao Z., Tang B. Z., Chem. Eng. J. 2023, 466, 143353. [Google Scholar]
  • 21.a) Cai X.‐M., Zhang X., Lin Y., Tang Z., Huang S., J. Mol. Struct. 2023, 1272, 134230; [Google Scholar]; b) Sun H., Tang X.‐X., Miao B.‐X., Yang Y., Ni Z., Sens. Actuators B Chem. 2018, 267, 448. [Google Scholar]
  • 22.a) Li A.‐L., Wang Z.‐L., Wang W.‐Y., Liu Q.‐S., Sun Y., Wang S.‐F., Gu W., Microchem. J. 2021, 160, 105682; [Google Scholar]; b) Sun L., Wang Z., Chen L., Sun X., Yang Z., Gu W., Analyst 2023, 148, 1867; [DOI] [PubMed] [Google Scholar]; c) Meng Z., Wang Z., Liang Y., Zhou G., Li X., Xu X., Yang Y., Wang S., Int. J. Biol. Macromol. 2023, 239, 124261. [DOI] [PubMed] [Google Scholar]
  • 23. Piyanuch P., Wangngae S., Kamkaew A., Wattanathana W., Wannapaiboon S., Impeng S., Maneeprakorn W., Promarak V., Chansaenpak K., Dyes Pigm. 2022, 205, 110532. [Google Scholar]
  • 24. Khoshsoroor S., Mohammadi A., Khalili B., Mohammadi S., J. Photochem. Photobiol. A 2020, 388, 112208. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information

Data Availability Statement

The data that support the findings of this study are available from the corresponding author upon reasonable request.


Articles from Advanced Science are provided here courtesy of Wiley

RESOURCES